共查询到20条相似文献，搜索用时 437 毫秒
1.
BPIV-3和BVDV双重RT-PCR快速检测方法的建立 总被引：1，自引：0，他引：1
参照GenBank中登录的牛副流感病毒3型(BPIV-3)和牛病毒性腹泻病毒(BVDV)全基因序列,分别针对BPIV3特异性NP蛋白保守基因和BVDV保守区段E2基因设计2对引物,经优化反应条件建立了快速鉴别BPIV-3和BVDV的双重RT-PCR诊断方法。最佳扩增条件为94℃30s,56.2℃30s,72℃1min,循环30次;72℃延伸5min,16℃10min;BVDV引物浓度为1.0μmol/L,BPIV-3引物浓度为0.5μmol/L。采用该方法检测BPIV-3和BVDV参考病毒株,能同时扩增出预期为425bp和294bp大小的特异性片段,而扩增牛传染性鼻气管炎病毒、牛合胞体病毒、猪瘟病毒以及牛支原体、致病性大肠埃希菌、多杀性巴氏杆菌A型、化脓隐秘杆菌和鼠伤寒沙门菌等均呈阴性反应。对参考病毒株进行梯度稀释检测,结果证明该方法检测BPIV-3的灵敏度可达10-3 TCID50/0.1mL,而BVDV的灵敏度达102 TCID50/0.1mL。 相似文献
2.
副鸡嗜血杆菌PCR检测方法的建立 总被引：2，自引：0，他引：2
参照GenBank中已发表的副鸡嗜血杆菌血凝素（HA）基因设计合成了一对引物，预计扩增片段大小约为412bp。利用这对引物，通过对PCR反应体系和反应条件的优化，建立了针对副鸡嗜血杆菌的PCR检测方法。结果表明，该方法敏感性较高，最低可检出1．7×10^4CFU／mL的副鸡嗜血杆菌，对副猪嗜血杆菌、巴氏杆菌、大肠杆菌、沙门氏菌在相同反应条件下未扩增出任何片段，说明该方法具有较好的特异性。 相似文献
3.
用马丁干粉和马丁肉汤培养基培养猪多杀性巴氏杆菌,分别生产3批猪多杀性巴氏杆菌活疫苗。结果用马丁干粉培养基生产的制苗用菌液的活菌数分别为1．80×10^10CFU／mL、1.75×10^10CFU／mL、1.80×10^10CFU／mL：冻干后的存活率分别为64％、69％、67％。用马丁肉汤培养基生产的制苗用菌液的活菌数分别为1．20×10^10CFU／mL、1．50×10^10CFU／mL、1．10×10^10CFU／mL,冻干后的存活率分别为50％、49％、54％。用两种培养基制备的疫苗按《兽用生物制品检验标准》（以下简称《标准》）检验6批疫苗均合格。 相似文献
4.
为建立多重PCR方法用于禽源多杀性巴氏杆菌中毒力基因的检测,对禽源多杀性巴氏杆菌分离株MD-1的9个毒力基因进行PCR扩增及敏感性测定,然后通过多个基因的组合得到5种多重PCR体系,并从中筛选合适的多重PCR体系,测定其特异性、敏感性和重复性。结果显示,分离株MD-1中的9个毒力基因均可扩增出目的片段,敏感性测定结果表明,有的基因可检测至1.81×10~4 copies/μL的核酸。筛选出的4种多重PCR体系1、3或4、5均可用于其中6个毒力基因(pfhA、nanB、ompH、oma87、sodA、sodC)的检测,并且特异性较强,均能够扩增禽源多杀性巴氏杆菌分离株HN-1和CZ-6,而大肠埃希菌和沙门菌分离株均无扩增条带。多重PCR体系1、3、4可检测多杀性巴氏杆菌核酸的敏感性为1.81×10~6 copies/μL,多重PCR体系5甚至可检测至1.81×10~5 copies/μL,同时这4种多重PCR体系与单个毒力基因PCR检测的敏感性均一致。说明建立的禽源多杀性巴氏杆菌毒力基因的多重PCR检测方法对多杀性巴氏杆菌毒力基因的快速检测有参考价值。 相似文献
5.
猪多杀性巴氏杆菌PCR检测方法的建立及其应用 总被引：2，自引：0，他引：2
设计了1对用以检测猪多杀性巴氏杆菌的引物。对临床送检的有肺炎症状或萎缩性鼻炎症状的发病猪的病料进行细菌培养．然后挑菌做PCR，同时对可疑菌落纯化培养后做生化鉴定。结果，从不同省(市)的送检病料中分离鉴定出66株多杀性巴氏杆菌，PCR检测结果与生化鉴定结果完全符合；该引物对其他6种猪的常见呼吸道病原菌的扩增结果均为阴性；该PCR检测方法能检出CFU为10^3／mL的巴氏杆菌模板。 相似文献
6.
7.
副猪嗜血杆菌PCR快速诊断方法的建立 总被引：7，自引：0，他引：7
副猪嗜血杆菌营养要求比较苛刻,常规生化试验检测方法比较烦琐,本研究针对副猪嗜血杆菌16SrRNA基因特异性PCR引物序列,合成一对PCR引物,建立相应的PCR检测方法,同时对该方法的灵敏性、特异性等实验。结果显示可检测出浓度为2．8×10^3CFU／mL的副猪嗜血杆菌表明该方法灵敏度高;对大肠杆菌、链球菌、巴氏杆菌、沙门氏杆菌、金黄色葡萄球菌进行PCR扩增均不获得任何条带,表明该方法特异性较强。所以该方法对于临床快速检测副猪嗜血杆菌具有重要意义。 相似文献
8.
牛多杀性巴氏杆菌和牛支原体双重PCR检测方法的建立及应用 总被引：1，自引：0，他引：1
《中国奶牛》2015,(14)
参照Gen Bank中牛多杀性巴氏杆菌kmt1基因序列(AF016259)和牛支原体opp D/F基因序列(AF130119),设计两对引物,在建立两种细菌单项PCR检测方法的基础上,优化双重PCR反应条件,建立了两种细菌的双重PCR检测方法,用这两对引物对同一样品中的牛多杀性巴氏杆菌、牛支原体核酸为模板进行双重PCR扩增,结果可同时扩增牛多杀性巴氏杆菌和牛支原体的265bp和439bp的特异性片段,而对其他4种牛病原菌的扩增结果均为阴性。敏感性测定结果表明,对牛多杀性巴氏杆菌和牛支原体的最低核酸检出限均为1pg。通过对30份临床病料检测,将建立的双重PCR技术和单项PCR方法进行对比验证,结果显示,两者的总符合率为100%。结果表明,建立的双重PCR检测方法具有特异、快速、准确的特点,可用于对牛多杀性巴氏杆菌和牛支原体的同时检测和鉴别诊断。 相似文献
9.
为建立一种特异性强且敏感性高的兔源A型多杀性巴氏杆菌快速检测方法，本研究以兔源A型多杀性巴氏杆菌kmt1和hyaD基因为目的基因，设计2对特异性引物进行双重PCR扩增，经反应条件优化，建立检测兔源A型多杀性巴氏杆菌的双重PCR方法。该方法的最佳退火温度为57.8℃，最佳混合引物浓度为0.8μmol/L。该方法特异性强，对兔源A型多杀性巴氏杆菌为kmt1和hyaD基因双阳性，对兔源D型和F型多杀性巴氏杆菌为kmt1基因单阳性，对兔源其它细菌性病原和阴性对照则均为阴性。该方法敏感性高，对兔源A型多杀性巴氏杆菌kmt1和hyaD基因的最低检出限分别为1×103拷贝/μL和1×104拷贝/μL。该方法重复性好，且与已报道的多重PCR方法的符合率高达96.12%。本研究建立的双重PCR方法对兔源A型多杀性巴氏杆菌具有良好的特异性和敏感性，且重复性好、准确性高，为该病原的快速检测提供了有力的技术支持。 相似文献
10.
参考GenBank中兔巴氏杆菌16SrRNA和波氏杆菌的fim2的基因序列,应用Premier 5.0软件在二者高度保守区设计了2对引物,建立了适合巴氏杆菌和波氏杆菌快速检测的多重PCR检测方法。以该方法对巴氏杆菌和波氏杆菌参考菌株进行PCR扩增,分别能从各自的基因组中扩增出与试验设计相符的644bp和425bp的特异性DNA片段。将扩增所得的DNA片段进行克隆测序,测序结果表明分别为巴氏杆菌16SrRNA和波氏杆菌fim2基因序列。该方法对波氏杆菌的检测下限为4×102 CFU,对巴氏杆菌的检测下限为6×101 CFU。对兔源性沙门菌、葡萄球菌、大肠杆菌、魏氏梭菌扩增结果为阴性。表明所建立的RT-PCR检测技术具有特异、快速和敏感的特点,可用于鉴别诊断兔巴氏杆菌和波氏杆菌以及2者混合感染。 相似文献
11.
[目的]牛支原体肺炎是严重危害国内外肉牛养殖业的一种重要疾病,病原混合感染将加剧病情,增加临床治疗难度。本研究通过阐明我国牛支原体肺炎混合感染情况,为探讨更加有效的防控手段提供参考依据。[方法]近4年来采用门诊和出诊的方式,收集了全国范围内35个临床初诊为牛支原体肺炎的牛场病牛样本,进行牛支原体及混合感染细菌的分离和分型鉴定。[结果]确定了这类疾病的细菌学感染特征,表现为牛支原体感染占绝对优势,混合感染模式主要以牛支原体合并多杀性巴氏杆菌A型感染、牛支原体合并和化脓隐秘杆菌感染为主。[结论]经实验室检测证实临床初诊病例绝大部分为牛支原体肺炎,但混合感染很普遍。 相似文献
12.
2018年天津市原料奶细菌总数、体细胞数及奶牛乳房炎病原菌、耐药基因调研报告 总被引：1，自引：0，他引：1
本研究旨在调查天津市原料奶细菌总数、体细胞数及乳房炎病原菌、耐药基因,了解全市原料奶的质量状况及引起奶牛乳房炎发生的主要原因。采集天津市5家乳品加工企业奶罐车的原料奶样品,用于检测体细胞数和菌落总数;采集天津市奶牛养殖场储奶罐奶样品,用于检测体细胞数;采集奶牛场临床型乳房炎发病乳区的牛奶样品,用于检测乳房炎病原菌及耐药基因。结果显示:2018年天津市乳品加工企业原料奶体细胞数平均值为44.65万/mL,标准差42.41万/mL,变异系数94.97%,最大值为225.50万/mL,最小值为1.20万/mL,SCC≤50万/mL的样品占74.37%,50万/mL200万/mL的样品占3.13%;细菌总数平均值11.54万CFU/mL,标准差26.28万CFU/mL,变异系数227.66%,最大值190.00万CFU/mL,最小值0.095万CFU/mL,细菌总数≤10万CFU/mL的样品占74.37%,10万CFU<细菌总数≤50万CFU/mL的样品占21.25%,50万CFU<细菌总数≤100万CFU/mL的样品占1.88%,100万CFU/mL<细菌总数≤200万CFU/mL的样品占2.50%。2018年天津市奶牛养殖场原料奶体细胞数平均值为38.81万/mL,标准差36.49万/mL,变异系数94.03%,最大值为210.00万/mL,最小值为0.80万/mL,SCC≤50万/mL的样品占79.17%,50万/mL200万/mL的样品占0.83%。乳房炎病原菌检测结果显示:36个样品检出病原菌,总检出率为94.74%;共检出8种病原菌,检出率最高的是乳房链球菌,检出率为73.68%,其他病原体检出率依次为:牛支原体34.21%,牛棒状杆菌13.16%,无乳链球菌10.53%,大肠杆菌5.26%,白色念球菌5.26%,停乳链球菌2.63%,铜绿假单胞菌2.63%。14个样品检出耐药基因,总检出率为36.84%;2种耐药基因的检出率分别为β-内酰胺耐药基因CTX-M934.21%,耐甲氧西林葡萄球菌耐药基因MecA 2.63%。研究表明,2018年天津市原料奶SCC及细菌总数大部分接近欧盟标准,但仍有待进一步提高;引起天津地区临床型乳房炎的3种主要致病菌为乳房链球菌、牛支原体和牛棒状杆菌。 相似文献
13.
牛呼吸道综合征往往是多种病原体混合感染引起,致病机制复杂。云南省昆明市某肉牛养殖场部分犊牛出现了以咳嗽、气短、流鼻涕、腹泻等呼吸道症状为主要表现的呼吸道疾病,随后多头相继死亡,剖检主要病变为气管、胃黏膜、小肠出血,肺脏肝变,肝脏出血肿大,心脏出血,心包黏连等;经采病料用常见呼吸道疾病病原（牛病毒性腹泻病毒,牛冠状病毒,牛副流感病毒3型,牛呼吸道合胞体病毒,牛疱疹病毒1型,多杀性巴氏杆菌,溶血性曼氏杆菌,牛支原体）8联PCR检测试剂盒检测,结果为副流感病毒3型、多杀性巴氏杆菌、牛支原体混合感染。经用加米霉素、10%替米考星和20%氟苯尼考等大环内酯类药物治疗,结合加强饲养管理,多数病牛恢复了健康。 相似文献
14.
The objective of this study was to determine the potential of Bdellovibrio bacteriovorus 109J as an alternative non-chemotherapeutic treatment of infectious bovine keratoconjunctivitis (IBK). To accomplish this, various parameters of B. bacteriovorus predation of Moraxella bovis were determined in vitro. Initial passage of B. bacteriovorus using M. bovis as prey required 10 d for active cultures to develop compared with 2 d for culture on normal Escherichia coli prey; however by the 5th passage, time to active predatory morphology was reduced to 2 d. This high passage B. bacteriovorus culture [1 × 10(10) plaque forming units (PFU)/mL] killed 76% of M. bovis [1 × 10(7) colony forming units (CFU)/mL] present in suspension broth in a 4 h assay. The minimal level of M. bovis supporting B. bacteriovorus predation was 1 × 10(4) CFU/mL. To assess the ability of B. bacteriovorus to kill M. bovis on an epithelial surface mimicking IBK, an in vitro assay with Madin-Darby bovine kidney (MDBK) cells inoculated with 4 × 10(7) CFU/mL M. bovis was used. Treatment with a B. bacteriovorus suspension (1.6 × 10(11) PFU/mL) decreased adherence of M. bovis to MDBK cells by 6-fold at 12 h of treatment, as well as decreased the number of unattached M. bovis cells by 1.4-fold. This study demonstrates that B. bacteriovorus has potential as an effective biological control of M. bovis at levels likely present in IBK-infected corneal epithelia and ocular secretions. 相似文献
15.
Mycoplasma agalactiae subsp. bovis in pneumonia and arthritis of the bovine. 总被引：1，自引：1，他引：0 
下载免费PDF全文
下载免费PDF全文 E V Langford 《Canadian journal of veterinary research》1977,41(1):89-94
The pneumonic lungs of 42 cattle from 26 feedlots were examined for the presence of mycoplasma, pathogenic bacteria and viruses. Four animals representative of two lots failed to yield mycoplasma. One of these yielded the virus of infectious bovine rhinotracheitis and Pasteurella hemolytica, the other yielded only P. P. multocida. Nine animals in eight lots yielded Mycoplasma sp.: five of these were M. bovirhinis, two were M. arginini and two were untypable. All of these animals yielded one or more of P. hemolytica, P. multiocida, infectious bovine rhinotracheitis virus or bovine virus diarrhea virus. Twenty-five of 29 animals in 16 lots yieled M. agalactiae subsp. bovis from lung tissues. The same organism was recovered from the arthritic joints of 12 of these animals. Eight of the 25 animals yielded no other pathogen and all of these had not received any treatment. Nine of the 25 M. agalactiae subsp. bovis positive animals also yielded one or more of P. hemolytica, P. multocida, Corynebacterium pyogenes or infectious bovine rhinotracheitis virus. Bacteriological and virological studies were not completed for the remaining eight of the 25 positive animals. In five lots of cattle which had not received medication for pneumonia and for arthritis only M. agalactiae subsp. bovis was recovered. Twenty-five grossly normal lungs obtained from normal cattle at the time of slaughter were cultured and all were negative. The possible role of M. agalactiae subsp. bovis in pneumonia and arthritis was discussed. 相似文献
16.
Vogel G Nicolet J Martig J Tschudi P Meylan M 《Schweizer Archiv für Tierheilkunde》2001,143(7):341-350
The population under study included young calves with pneumonia (group A, n = 13) and their controls (group B, n = 9), as well as older calves from which the lungs with (group C, n = 90) or without (group D, n = 10) lesions were collected after slaughter. Arcanobacterium pyogenes was the organism most commonly isolated from calves in group A (46%), followed by Haemophilus somnus (23%), Mannheimia haemolytica (15%), Streptococcus suis and Pasteurella multocida (7.7% each). Only S. suis (22%) and P. multocida (11%) were found in group B. P. multocida was isolated from 32% group C calves, H. somnus from 11%, A. pyogenes from 7.8%, M. haemolytica from 2.2% and S. suis from 1.1%. No specific pathogens were isolated in group D. Prevalence of Mycoplasma bovis infection was 69% in group A and 37% in group C. Ninety-eight strains were tested for resistAnce to antibiotics. Resistance to penicillin and ampicillin was present only in M. haemolytica (46%). High percentages of resistant strains were observed for streptomycin (48-100%), tetracycline (15-43%), sulfonamides alone (14-100%) or in combination with trimethoprim (0-100%). Therapeutic approaches to bacterial calf pneumonia in the area under study should be modified according to the isolated bacterial population, the observed antimicrobial resistances and the growing importance of Mycoplasma bovis. 相似文献
17.
Cho YS Lee HS Lim SK Joo YS Kim JM Kim JH 《The Journal of veterinary medical science / the Japanese Society of Veterinary Science》2008,70(9):959-964
Bovine bacterial respiratory diseases have been one of the most serious problems due to their high mortality and economic loss in calves. The vaccinations of bovine bacterial respiratory vaccines have been complex because of no multivalent vaccine. In this study, novel multivalent bovine bacterial respiratory vaccine (BRV) was developed and tested for its safety and efficacy. BRV was composed of two immunogens and five bacterins. These were leukotoxoid and bacterin of Mannheimia haemolytica type A, outer membrane protein and bacterin of Pasteurella multocida type A, and bacterins of Haemophilus somnus, Mycoplasma bovis, and Arcanobacterium pyogenes. ELISA antibody titers to five bacterial antigens in vaccinated guinea pigs increased, compared with those in unvaccinated ones. BRV was safe for calves and pregnant cattle in this study. In calves challenged with M. haemolytica and P. multocida, the average daily weight gain and antibody titers of vaccinated calves increased, and respiratory symptoms (P<0.05) and treatment frequency (P<0.01) of vaccinated calves significantly decreased, compared with those of unvaccinated calves. Interestingly, the antibody titers of M. haemolytica leukotoxoid and Mycoplasma bovis were closely related with the reduction of respiratory symptoms. BRV would be an ecomonical measure for the protection against bovine bacterial respiratory diseases. 相似文献
18.
牛支原体单克隆抗体的制备与鉴定 总被引：1，自引：1，他引：0
以牛支原体(Mycoplasma bovis)湖北分离株HB0801作为抗原免疫8周龄BALB/c小鼠,利用杂交瘤技术筛选出了6株能稳定分泌抗牛支原体的单克隆抗体细胞株,分别生产腹水并对单抗进行了纯化和特性鉴定。经亚型测定,这些单抗都属IgG类。腹水ELISA效价在1×105~1.6×106。ELISA特异性分析结果表明,6株单抗与临床分离的牛支原体菌株以及ATCC标准株PG45都显阳性反应,但与牛的其他常见病原菌如多杀性巴氏杆菌、化脓隐秘杆菌等都显阴性反应。所有制备的单抗都与无乳支原体有交叉反应,其中两株单抗1A5和1C11只与无乳支原体有交叉反应,与其他支原体无交叉反应。经Western blotting验证,6株单抗分别识别牛支原体全菌蛋白中的不同条带,说明分别针对不同的蛋白抗原。这些牛支原体单克隆抗体为后期建立牛支原体检测方法及致病机理研究奠定了良好基础。 相似文献
19.
An investigation of the aetiological role of bovine herpesvirus 4 in bovine endometritis 总被引：2，自引：0，他引：2
Fábián K Makrai L Sachse K Szeredi L Egyed L 《Veterinary journal (London, England : 1997)》2008,177(2):289-292
Uteri from 31 infertile cattle were examined for the presence of bovine herpesvirus 4 (BoHV-4) by nested polymerase chain reaction (PCR). Samples were also tested for bacteria, including chlamydiae and Mycoplasma bovis. BoHV-4 was detected by PCR in 27/31 (87.1%) samples, but the presence and amount of viral DNA was not correlated with histological and bacteriological findings. Arcanobacterium pyogenes, Histophilus somni and Pasteurella multocida were isolated from five cows with endometritis. Chlamydiae were detected in four cases (12.9%), but only two of these had endometritis. The study does not support a role for BoHV-4 as primary agent in bovine endometritis. 相似文献
20.
Wedlock DN Aldwell FE Vordermeier HM Hewinson RG Buddle BM 《Veterinary immunology and immunopathology》2011,144(3-4):220-227
Mycobacterium bovis bacille Calmette-Guérin (BCG) delivered to calves by the oral route in a formulated lipid matrix has been previously shown to induce protection against bovine tuberculosis. A study was conducted in cattle to determine if a combination of a low dose of oral BCG and a protein vaccine could induce protective immunity to tuberculosis while not sensitising animals to tuberculin. Groups of calves (10 per group) were vaccinated by administering 2 × 10(7)colony forming units (CFU) of BCG orally or a combination of 2 × 10(7)CFU oral BCG and a protein vaccine comprised of M. bovis culture filtrate proteins (CFP) formulated with the adjuvants Chitin and Gel 01 and delivered by the intranasal route, or CFP formulated with Emulsigen and the TLR2 agonist Pam(3)CSK(4) and administered by the subcutaneous (s.c.) route. Two further groups were vaccinated with the CFP/Chitin/Gel 01 or CFP/Emulsigen/Pam(3)CSK(4) vaccines alone. Positive control groups were given 10(8)CFU oral BCG or 10(6)CFU s.c. BCG while a negative control group was non-vaccinated. All animals were challenged with M. bovis 15 weeks after vaccination and euthanized and necropsied at 16 weeks following challenge. Groups of cattle vaccinated with s.c. BCG, 10(8)CFU or 2 × 10(7)CFU oral BCG showed significant reductions in seven, three and four pathological or microbiological disease parameters, respectively, compared to the results for the non-vaccinated group. There was no evidence of protection in calves vaccinated with the combination of oral BCG and CFP/Emulsigen/Pam(3)CSK(4) or oral BCG and CFP/Chitin/Gel 01 or vaccinated with the protein vaccines alone. Positive responses in the comparative cervical skin test at 12 weeks after vaccination were only observed in animals vaccinated with s.c. BCG, 10(8)CFU oral BCG or a combination of 2 × 10(7)CFU oral BCG and CFP/Chitin/Gel 01. In conclusion, co-administration of a protein vaccine, administered by either systemic or mucosal routes with oral BCG did not enhance the protection conferred by administration of oral BCG alone. 相似文献